Alliancebernstein L.P. Arvinas, Inc. Transaction History

Alliancebernstein L.P.

$261 Billion
Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Arvinas, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 73,720 shares of ARVN stock, worth $493,186. This represents 0.0% of its overall portfolio holdings.

Number of Shares

73,720

Previous 73,720 -0.0%

Holding current value

$493,186

Previous $1.41 Million 63.41%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.46 - $40.4 $421,935 - $696,900	17,250 Added 30.55%	73,720 $1.96 Million
Q1 2024 May 14, 2024	BUY	$36.38 - $52.31 $144,428 - $207,670	3,970 Added 7.56%	56,470 $2.33 Million
Q2 2023 Aug 15, 2023	SELL	$21.73 - $31.43 $1.09 Million - $1.57 Million	-50,000 Reduced 48.78%	52,500 $1.3 Million
Q1 2023 May 15, 2023	SELL	$26.15 - $37.26 $873,410 - $1.24 Million	-33,400 Reduced 24.58%	102,500 $2.8 Million
Q4 2022 Feb 14, 2023	BUY	$32.47 - $57.24 $2.6 Million - $4.58 Million	80,000 Added 143.11%	135,900 $4.65 Million
Q3 2022 Nov 15, 2022	SELL	$41.87 - $57.99 $2.67 Million - $3.7 Million	-63,885 Reduced 53.33%	55,900 $2.49 Million
Q2 2022 Aug 15, 2022	BUY	$36.01 - $74.24 $2.44 Million - $5.04 Million	67,829 Added 130.55%	119,785 $5.04 Million
Q1 2022 May 13, 2022	BUY	$60.27 - $81.57 $21,456 - $29,038	356 Added 0.69%	51,956 $3.5 Million
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $223,889 - $327,114	-3,400 Reduced 6.18%	51,600 $4.24 Million
Q3 2021 Nov 10, 2021	BUY	$73.2 - $107.87 $14,640 - $21,574	200 Added 0.36%	55,000 $4.52 Million
Q2 2021 Jul 30, 2021	BUY	$60.45 - $84.26 $459,420 - $640,376	7,600 Added 16.1%	54,800 $4.22 Million
Q1 2021 May 06, 2021	BUY	$58.19 - $91.37 $29,095 - $45,685	500 Added 1.07%	47,200 $3.12 Million
Q3 2020 Nov 12, 2020	SELL	$22.99 - $36.34 $13,793 - $21,804	-600 Reduced 1.27%	46,700 $1.1 Million
Q2 2020 Aug 13, 2020	BUY	$29.88 - $56.74 $657,360 - $1.25 Million	22,000 Added 86.96%	47,300 $1.59 Million
Q1 2020 May 14, 2020	BUY	$33.0 - $54.5 $79,200 - $130,800	2,400 Added 10.48%	25,300 $1.02 Million
Q4 2019 Feb 18, 2020	BUY	$15.39 - $44.38 $98,496 - $284,032	6,400 Added 38.79%	22,900 $941,000
Q3 2019 Nov 14, 2019	BUY	$21.55 - $27.61 $64,650 - $82,830	3,000 Added 22.22%	16,500 $356,000
Q2 2019 Aug 14, 2019	BUY	$15.96 - $23.8 $215,460 - $321,300	13,500 New	13,500 $297,000

Others Institutions Holding ARVN

# of Institutions

246

Shares Held

62.5M

Call Options Held

2.65M

Put Options Held

1.1M

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $356M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Arvinas, Inc. Transaction History